These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8444668)

  • 1. Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.
    Thal LA; Vazquez J; Perri MB; Beckley A; Donabedian S; Kaatz GW; Patterson JE; Zervos MJ
    J Antimicrob Chemother; 1993 Jan; 31(1):182-5. PubMed ID: 8444668
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci.
    Patterson JE; Farrel P; Zervos MJ
    Diagn Microbiol Infect Dis; 1991; 14(6):495-9. PubMed ID: 1802536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
    Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
    Bayer AS; Tu J
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1068-74. PubMed ID: 2118323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.
    Sierra-Hoffman M; Iznaola O; Goodwin M; Mohr J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6064. PubMed ID: 22964255
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ampicillin/sulbactam against enterococci determined by the time-kill method.
    D'Amato RF; Mathew A; Hochstein L; Cleri DJ; Johnson J
    Diagn Microbiol Infect Dis; 1989; 12(1):9-11. PubMed ID: 2496949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Kartalija M; Sande M
    J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    Vazquez J; Perri MB; Thal LA; Donabedian SA; Zervos MJ
    J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM; Thauvin-Eliopoulos C; Moellering RC
    Clin Infect Dis; 1992 Jul; 15(1):58-62. PubMed ID: 1319757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
    Landman D; Quale JM; Mobarakai N; Zaman MM
    J Antimicrob Chemother; 1995 Jul; 36(1):253-8. PubMed ID: 8537276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Fournier MA
    J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.
    Zinner SH; Gilbert D; Dudley MN
    Antimicrob Agents Chemother; 1998 Jan; 42(1):72-7. PubMed ID: 9449263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose ampicillin for the treatment of high-level aminoglycoside resistant enterococcal endocarditis.
    Jones BL; Ludlam HA; Brown DF
    J Antimicrob Chemother; 1994 Apr; 33(4):891-2. PubMed ID: 8056716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.